Global Wealth Management Investment Advisory, Inc. Bristol Myers Squibb CO Transaction History

Global Wealth Management Investment Advisory, Inc.

$462 Million
Q3 2024

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	BUY	$48.48 - $57.85 $5,235 - $6,247	108 Added 38.99%	385 $19,000
Q2 2023 Aug 10, 2023	BUY	$63.71 - $70.74 $17,647 - $19,594	277 New	277 $17,000
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $2,076 - $2,335	-35 Reduced 11.22%	277 $17,000
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $2,020 - $2,290	35 Added 12.64%	312 $19,000
Q3 2020 Nov 16, 2020	SELL	$57.43 - $63.64 $103,374 - $114,552	-1,800 Reduced 86.66%	277 $17,000
Q2 2020 Aug 12, 2020	SELL	$54.82 - $64.09 $10,744 - $12,561	-196 Reduced 8.62%	2,077 $122,000
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $19,388 - $25,290	394 Added 20.97%	2,273 $146,000
Q2 2019 Aug 20, 2019	SELL	$44.62 - $49.34 $7,808 - $8,634	-175 Reduced 8.52%	1,879 $85,000
Q1 2019 May 10, 2019	SELL	$45.12 - $53.8 $119,974 - $143,054	-2,659 Reduced 56.42%	2,054 $98,000
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $229,805 - $298,002	4,713 New	4,713 $245,000

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11.1 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.34 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.47 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.59 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.59 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Wealth Management Investment Advisory, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Global Wealth Management Investment Advisory, Inc. with notifications on news.

Account